• Interleukin-35 Modulates Ferroptosis and NETs in CS-Exposed

  2026-05-09

  This study reveals that interleukin-35 (IL-35) mitigates asthma exacerbation under cigarette smoke exposure by inhibiting neutrophil extracellular traps (NETs) through the gp130/STAT3/ferroptosis axis. The findings offer novel mechanistic insight into Th17/Treg immune balance and suggest targeted strategies for managing neutrophilic inflammation in smoking-related asthma.

• Triiodothyronine (T3): Precision in Thyroid Hormone Signalin

  2026-05-08

  Triiodothyronine (T3) from APExBIO empowers researchers to precisely dissect thyroid hormone signaling, metabolic regulation, and gene expression in advanced cellular models. Unlock robust, reproducible experiments with optimized protocols and actionable troubleshooting strategies for metabolic and endocrinology research.

• Procainamide Hydrochloride: Cardiac Sodium Channel Blocker F

  2026-05-08

  Procainamide Hydrochloride is a validated cardiac sodium channel blocker with reproducible inhibition of Nav1.5 and DNMT1, supporting research in arrhythmia and epigenetics. Its solubility, purity, and workflow integration are documented, making it a reliable tool for cardiac electrophysiology and related studies.

• Cy3 NHS Ester (Non-Sulfonated): Protein & Oligonucleotide La

  2026-05-07

  Cy3 NHS ester (non-sulfonated) enables robust, orange-fluorescent labeling of amino groups in proteins, peptides, and oligonucleotides for sensitive detection in imaging and analytical workflows. It is best suited for researchers who require strong signal intensity and compatibility with organic co-solvents, but is not recommended where water-only protocols or long-term dye solutions are needed.

• Cycloheximide: Strategic Insights for Protein Synthesis Inhi

  2026-05-07

  This thought-leadership article explores the mechanistic and translational nuances of cycloheximide as a protein biosynthesis inhibitor. We bridge recent discoveries in apoptosis regulation, highlight evidence from age-related cataract studies, and provide actionable guidance for experimental design. By contextualizing APExBIO’s Cycloheximide (A8244) within the competitive landscape and emerging translational needs, this piece offers a uniquely strategic perspective for biomedical researchers.

• Pulchinenoside B4 Inhibits CD1d/NLRP3 to Alleviate Colitis

  2026-05-06

  This study demonstrates that Pulchinenoside B4 (PB4) alleviates DSS-induced colitis in mice by targeting CD1d-dependent NLRP3 inflammasome activation in macrophages. By elucidating the AKT-STAT1-PRDX1-NF-κB signaling axis, the research provides a mechanistic foundation for developing novel anti-colitis agents with greater specificity and reduced side effects.

• Macrophage EV miR-660 Drives Breast Cancer via NF-κB Activat

  2026-05-06

  This study reveals that extracellular vesicles from tumor-associated macrophages carry microRNA-660, which silences KLHL21 and activates the NF-κB pathway, thereby promoting breast cancer cell invasion, migration, and metastasis. These findings clarify a critical tumor-promoting communication axis in the breast tumor microenvironment and highlight new avenues for therapeutic intervention.

• CARMIL’s Membrane-Binding Domain: Mechanisms in Actin Regula

  2026-05-05

  The referenced study elucidates how the membrane-binding (MB) domain of CARMIL orchestrates the spatial and functional regulation of actin assembly at the plasma membrane. Through domain-specific experiments, it demonstrates that the MB domain not only targets CARMIL and capping protein (CP) to membrane sites but also actively promotes CP activation and release, advancing our understanding of cytoskeletal remodeling.

• Firefly Luciferase mRNA (ARCA, 5-moUTP): Mechanism & Benchma

  2026-05-05

  Firefly Luciferase mRNA (ARCA, 5-moUTP) is a highly stable and efficient bioluminescent reporter mRNA, incorporating ARCA capping and 5-methoxyuridine modifications to maximize protein expression and minimize innate immune activation. The product supports reproducible gene expression assays and in vivo imaging, as verified by both product documentation and peer-reviewed advances in mRNA delivery and stabilization.

• Distinct Mechanisms of Gepotidacin vs. Fluoroquinolones on D

  2026-05-04

  This article explores how gepotidacin, a novel bacterial topoisomerase inhibitor, interacts with Staphylococcus aureus gyrase in ways distinct from fluoroquinolone antibiotics. The reference study provides structural and mechanistic insights critical for antibiotic toxicity research and informs future directions in combating antimicrobial resistance.

• Applied Excellence with Prestained Protein Marker: Triple Co

  2026-05-04

  Unlock reliable SDS-PAGE and Western blot workflows with the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) from APExBIO. This marker streamlines molecular weight estimation, enhances transfer verification, and is fully compatible with phosphoproteomics and fluorescent imaging applications.

• Crizotinib Hydrochloride in Personalized Kinase Inhibitor As

  2026-05-03

  Explore how Crizotinib hydrochloride, a leading ALK kinase inhibitor, enables precise and reproducible inhibition studies within advanced assembloid models. This article uniquely guides assay optimization for cancer research using state-of-the-art patient-derived systems.

• PTGER4 Signaling Regulates HDAC Activity and SPINK4 in Recta

  2026-05-02

  Anbazhagan et al. (2024) revealed that PTGER4 signaling modulates class IIa HDAC function and SPINK4 mRNA levels in rectal epithelial cells, establishing a mechanistic link between mesenchymal stromal cell-derived PGE2 and epithelial barrier regulation. These findings provide new molecular insights relevant to intestinal homeostasis and inflammation.

• Bafilomycin C1: Precision V-ATPase Inhibition in iPSC Phenot

  2026-05-01

  Explore how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, underpins next-generation high-content phenotypic assays using iPSC-derived cells. This article uniquely bridges mechanistic insight with rigorous assay design for translational research.

• 3-Deazaadenosine: Applied Workflows for Methylation and Anti

  2026-05-01

  3-Deazaadenosine offers researchers a powerful, dual-purpose tool for dissecting methylation-dependent pathways and modeling antiviral responses, with clear advantages in both epigenetic and infectious disease research. This article unpacks practical workflows, troubleshooting strategies, and validated protocol enhancements to maximize experimental clarity with this potent S-adenosylhomocysteine hydrolase inhibitor.

16159 records 1/1078 page Next 12345 下5页 Last page